Massimo Porta

13PUBLICATIONS
12CO-AUTHORS
Disease surveillanceMedical infection agents (incl. prions)Microbial geneticsSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes.

|Jan 11, 2024
Release of Pro-Inflammatory/Angiogenic Factors by Retinal Microvascular Cells Is Mediated by Extracellular Vesicles Derived from M1-Activated Microglia.

Elena Beltramo, Aurora Mazzeo, Massimo Porta

|May 28, 2022
Characterization of an Immortalized Human Microglial Cell Line as a Tool for the Study of Diabetic Retinopathy.

Aurora Mazzeo, Massimo Porta, Elena Beltramo

|Nov 22, 2020
One hundred years ago: the dawning of the insulin era.

Massimo Porta

|Jul 14, 2020
Effects of thiamine and fenofibrate on high glucose and hypoxia-induced damage in cell models of the inner blood-retinal barrier.

Aurora Mazzeo, Chiara Gai, Marina Trento

|Apr 30, 2020
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.

Cristina Hernández, Massimo Porta, Francesco Bandello

Pageof 3

Frequent Collaborators

4 joint publications

Elena Beltramo

2 joint publications

Rafael Simó

2 joint publications

Cristina Hernández

1 joint publications

José Cunha-Vaz